0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI-powered Cancer Diagnostic Tool Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-29K18806
Home | Market Reports | Health| Health Conditions| Cancer
Global AI powered Cancer Diagnostic Tool Market Research Report 2025
BUY CHAPTERS

Global AI-powered Cancer Diagnostic Tool Market Research Report 2025

Code: QYRE-Auto-29K18806
Report
March 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI-powered Cancer Diagnostic Tool Market Size

The global market for AI-powered Cancer Diagnostic Tool was valued at US$ 25.6 million in the year 2024 and is projected to reach a revised size of US$ 115 million by 2031, growing at a CAGR of 24.6% during the forecast period.

AI-powered Cancer Diagnostic Tool Market

AI-powered Cancer Diagnostic Tool Market

AI-powered cancer diagnostic tools are transforming oncology by leveraging machine learning, deep learning, and computer vision to detect cancer earlier, more accurately, and efficiently than traditional methods. These AI tools assist doctors in analyzing medical images, identifying biomarkers, and predicting treatment outcomes, ultimately improving patient survival rates.
North American market for AI-powered Cancer Diagnostic Tool is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AI-powered Cancer Diagnostic Tool is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for AI-powered Cancer Diagnostic Tool in Skin Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of AI-powered Cancer Diagnostic Tool include DermaSensor, Inc., Paige, Ibex, Roche, Volpara Health Limited, Bot Image, Inc., Quibim, Imagene AI, SkinVision, NIRAMAI Health Analytix, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI-powered Cancer Diagnostic Tool, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-powered Cancer Diagnostic Tool.
The AI-powered Cancer Diagnostic Tool market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI-powered Cancer Diagnostic Tool market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-powered Cancer Diagnostic Tool companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of AI-powered Cancer Diagnostic Tool Market Report

Report Metric Details
Report Name AI-powered Cancer Diagnostic Tool Market
Accounted market size in year US$ 25.6 million
Forecasted market size in 2031 US$ 115 million
CAGR 24.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company DermaSensor, Inc., Paige, Ibex, Roche, Volpara Health Limited, Bot Image, Inc., Quibim, Imagene AI, SkinVision, NIRAMAI Health Analytix, Vara, Gleamer, Lunit Inc., Monitor Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of AI-powered Cancer Diagnostic Tool company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is AI-powered Cancer Diagnostic Tool Market growing?

Ans: The AI-powered Cancer Diagnostic Tool Market witnessing a CAGR of 24.6% during the forecast period 2025-2031.

What is the AI-powered Cancer Diagnostic Tool Market size in 2031?

Ans: The AI-powered Cancer Diagnostic Tool Market size in 2031 will be US$ 115 million.

Who are the main players in the AI-powered Cancer Diagnostic Tool Market report?

Ans: The main players in the AI-powered Cancer Diagnostic Tool Market are DermaSensor, Inc., Paige, Ibex, Roche, Volpara Health Limited, Bot Image, Inc., Quibim, Imagene AI, SkinVision, NIRAMAI Health Analytix, Vara, Gleamer, Lunit Inc., Monitor Corporation

What are the Application segmentation covered in the AI-powered Cancer Diagnostic Tool Market report?

Ans: The Applications covered in the AI-powered Cancer Diagnostic Tool Market report are Skin Cancer, Breast Cancer, Lung Cancer, Other

What are the Type segmentation covered in the AI-powered Cancer Diagnostic Tool Market report?

Ans: The Types covered in the AI-powered Cancer Diagnostic Tool Market report are Hardware, Software

Recommended Reports

AI Cancer Diagnosis

Medical Imaging AI

Cancer Diagnostic Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-powered Cancer Diagnostic Tool Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hardware
1.2.3 Software
1.3 Market by Application
1.3.1 Global AI-powered Cancer Diagnostic Tool Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Skin Cancer
1.3.3 Breast Cancer
1.3.4 Lung Cancer
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-powered Cancer Diagnostic Tool Market Perspective (2020-2031)
2.2 Global AI-powered Cancer Diagnostic Tool Growth Trends by Region
2.2.1 Global AI-powered Cancer Diagnostic Tool Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI-powered Cancer Diagnostic Tool Historic Market Size by Region (2020-2025)
2.2.3 AI-powered Cancer Diagnostic Tool Forecasted Market Size by Region (2026-2031)
2.3 AI-powered Cancer Diagnostic Tool Market Dynamics
2.3.1 AI-powered Cancer Diagnostic Tool Industry Trends
2.3.2 AI-powered Cancer Diagnostic Tool Market Drivers
2.3.3 AI-powered Cancer Diagnostic Tool Market Challenges
2.3.4 AI-powered Cancer Diagnostic Tool Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-powered Cancer Diagnostic Tool Players by Revenue
3.1.1 Global Top AI-powered Cancer Diagnostic Tool Players by Revenue (2020-2025)
3.1.2 Global AI-powered Cancer Diagnostic Tool Revenue Market Share by Players (2020-2025)
3.2 Global Top AI-powered Cancer Diagnostic Tool Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI-powered Cancer Diagnostic Tool Revenue
3.4 Global AI-powered Cancer Diagnostic Tool Market Concentration Ratio
3.4.1 Global AI-powered Cancer Diagnostic Tool Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-powered Cancer Diagnostic Tool Revenue in 2024
3.5 Global Key Players of AI-powered Cancer Diagnostic Tool Head office and Area Served
3.6 Global Key Players of AI-powered Cancer Diagnostic Tool, Product and Application
3.7 Global Key Players of AI-powered Cancer Diagnostic Tool, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-powered Cancer Diagnostic Tool Breakdown Data by Type
4.1 Global AI-powered Cancer Diagnostic Tool Historic Market Size by Type (2020-2025)
4.2 Global AI-powered Cancer Diagnostic Tool Forecasted Market Size by Type (2026-2031)
5 AI-powered Cancer Diagnostic Tool Breakdown Data by Application
5.1 Global AI-powered Cancer Diagnostic Tool Historic Market Size by Application (2020-2025)
5.2 Global AI-powered Cancer Diagnostic Tool Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI-powered Cancer Diagnostic Tool Market Size (2020-2031)
6.2 North America AI-powered Cancer Diagnostic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI-powered Cancer Diagnostic Tool Market Size by Country (2020-2025)
6.4 North America AI-powered Cancer Diagnostic Tool Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-powered Cancer Diagnostic Tool Market Size (2020-2031)
7.2 Europe AI-powered Cancer Diagnostic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI-powered Cancer Diagnostic Tool Market Size by Country (2020-2025)
7.4 Europe AI-powered Cancer Diagnostic Tool Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-powered Cancer Diagnostic Tool Market Size (2020-2031)
8.2 Asia-Pacific AI-powered Cancer Diagnostic Tool Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI-powered Cancer Diagnostic Tool Market Size by Region (2020-2025)
8.4 Asia-Pacific AI-powered Cancer Diagnostic Tool Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-powered Cancer Diagnostic Tool Market Size (2020-2031)
9.2 Latin America AI-powered Cancer Diagnostic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI-powered Cancer Diagnostic Tool Market Size by Country (2020-2025)
9.4 Latin America AI-powered Cancer Diagnostic Tool Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-powered Cancer Diagnostic Tool Market Size (2020-2031)
10.2 Middle East & Africa AI-powered Cancer Diagnostic Tool Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI-powered Cancer Diagnostic Tool Market Size by Country (2020-2025)
10.4 Middle East & Africa AI-powered Cancer Diagnostic Tool Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 DermaSensor, Inc.
11.1.1 DermaSensor, Inc. Company Details
11.1.2 DermaSensor, Inc. Business Overview
11.1.3 DermaSensor, Inc. AI-powered Cancer Diagnostic Tool Introduction
11.1.4 DermaSensor, Inc. Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.1.5 DermaSensor, Inc. Recent Development
11.2 Paige
11.2.1 Paige Company Details
11.2.2 Paige Business Overview
11.2.3 Paige AI-powered Cancer Diagnostic Tool Introduction
11.2.4 Paige Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.2.5 Paige Recent Development
11.3 Ibex
11.3.1 Ibex Company Details
11.3.2 Ibex Business Overview
11.3.3 Ibex AI-powered Cancer Diagnostic Tool Introduction
11.3.4 Ibex Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.3.5 Ibex Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche AI-powered Cancer Diagnostic Tool Introduction
11.4.4 Roche Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Volpara Health Limited
11.5.1 Volpara Health Limited Company Details
11.5.2 Volpara Health Limited Business Overview
11.5.3 Volpara Health Limited AI-powered Cancer Diagnostic Tool Introduction
11.5.4 Volpara Health Limited Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.5.5 Volpara Health Limited Recent Development
11.6 Bot Image, Inc.
11.6.1 Bot Image, Inc. Company Details
11.6.2 Bot Image, Inc. Business Overview
11.6.3 Bot Image, Inc. AI-powered Cancer Diagnostic Tool Introduction
11.6.4 Bot Image, Inc. Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.6.5 Bot Image, Inc. Recent Development
11.7 Quibim
11.7.1 Quibim Company Details
11.7.2 Quibim Business Overview
11.7.3 Quibim AI-powered Cancer Diagnostic Tool Introduction
11.7.4 Quibim Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.7.5 Quibim Recent Development
11.8 Imagene AI
11.8.1 Imagene AI Company Details
11.8.2 Imagene AI Business Overview
11.8.3 Imagene AI AI-powered Cancer Diagnostic Tool Introduction
11.8.4 Imagene AI Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.8.5 Imagene AI Recent Development
11.9 SkinVision
11.9.1 SkinVision Company Details
11.9.2 SkinVision Business Overview
11.9.3 SkinVision AI-powered Cancer Diagnostic Tool Introduction
11.9.4 SkinVision Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.9.5 SkinVision Recent Development
11.10 NIRAMAI Health Analytix
11.10.1 NIRAMAI Health Analytix Company Details
11.10.2 NIRAMAI Health Analytix Business Overview
11.10.3 NIRAMAI Health Analytix AI-powered Cancer Diagnostic Tool Introduction
11.10.4 NIRAMAI Health Analytix Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.10.5 NIRAMAI Health Analytix Recent Development
11.11 Vara
11.11.1 Vara Company Details
11.11.2 Vara Business Overview
11.11.3 Vara AI-powered Cancer Diagnostic Tool Introduction
11.11.4 Vara Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.11.5 Vara Recent Development
11.12 Gleamer
11.12.1 Gleamer Company Details
11.12.2 Gleamer Business Overview
11.12.3 Gleamer AI-powered Cancer Diagnostic Tool Introduction
11.12.4 Gleamer Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.12.5 Gleamer Recent Development
11.13 Lunit Inc.
11.13.1 Lunit Inc. Company Details
11.13.2 Lunit Inc. Business Overview
11.13.3 Lunit Inc. AI-powered Cancer Diagnostic Tool Introduction
11.13.4 Lunit Inc. Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.13.5 Lunit Inc. Recent Development
11.14 Monitor Corporation
11.14.1 Monitor Corporation Company Details
11.14.2 Monitor Corporation Business Overview
11.14.3 Monitor Corporation AI-powered Cancer Diagnostic Tool Introduction
11.14.4 Monitor Corporation Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025)
11.14.5 Monitor Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global AI-powered Cancer Diagnostic Tool Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Hardware
 Table 3. Key Players of Software
 Table 4. Global AI-powered Cancer Diagnostic Tool Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global AI-powered Cancer Diagnostic Tool Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global AI-powered Cancer Diagnostic Tool Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global AI-powered Cancer Diagnostic Tool Market Share by Region (2020-2025)
 Table 8. Global AI-powered Cancer Diagnostic Tool Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global AI-powered Cancer Diagnostic Tool Market Share by Region (2026-2031)
 Table 10. AI-powered Cancer Diagnostic Tool Market Trends
 Table 11. AI-powered Cancer Diagnostic Tool Market Drivers
 Table 12. AI-powered Cancer Diagnostic Tool Market Challenges
 Table 13. AI-powered Cancer Diagnostic Tool Market Restraints
 Table 14. Global AI-powered Cancer Diagnostic Tool Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global AI-powered Cancer Diagnostic Tool Market Share by Players (2020-2025)
 Table 16. Global Top AI-powered Cancer Diagnostic Tool Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-powered Cancer Diagnostic Tool as of 2024)
 Table 17. Ranking of Global Top AI-powered Cancer Diagnostic Tool Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by AI-powered Cancer Diagnostic Tool Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of AI-powered Cancer Diagnostic Tool, Headquarters and Area Served
 Table 20. Global Key Players of AI-powered Cancer Diagnostic Tool, Product and Application
 Table 21. Global Key Players of AI-powered Cancer Diagnostic Tool, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global AI-powered Cancer Diagnostic Tool Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global AI-powered Cancer Diagnostic Tool Revenue Market Share by Type (2020-2025)
 Table 25. Global AI-powered Cancer Diagnostic Tool Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global AI-powered Cancer Diagnostic Tool Revenue Market Share by Type (2026-2031)
 Table 27. Global AI-powered Cancer Diagnostic Tool Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global AI-powered Cancer Diagnostic Tool Revenue Market Share by Application (2020-2025)
 Table 29. Global AI-powered Cancer Diagnostic Tool Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global AI-powered Cancer Diagnostic Tool Revenue Market Share by Application (2026-2031)
 Table 31. North America AI-powered Cancer Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America AI-powered Cancer Diagnostic Tool Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America AI-powered Cancer Diagnostic Tool Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe AI-powered Cancer Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe AI-powered Cancer Diagnostic Tool Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe AI-powered Cancer Diagnostic Tool Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific AI-powered Cancer Diagnostic Tool Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific AI-powered Cancer Diagnostic Tool Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific AI-powered Cancer Diagnostic Tool Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America AI-powered Cancer Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America AI-powered Cancer Diagnostic Tool Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America AI-powered Cancer Diagnostic Tool Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa AI-powered Cancer Diagnostic Tool Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa AI-powered Cancer Diagnostic Tool Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa AI-powered Cancer Diagnostic Tool Market Size by Country (2026-2031) & (US$ Million)
 Table 46. DermaSensor, Inc. Company Details
 Table 47. DermaSensor, Inc. Business Overview
 Table 48. DermaSensor, Inc. AI-powered Cancer Diagnostic Tool Product
 Table 49. DermaSensor, Inc. Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 50. DermaSensor, Inc. Recent Development
 Table 51. Paige Company Details
 Table 52. Paige Business Overview
 Table 53. Paige AI-powered Cancer Diagnostic Tool Product
 Table 54. Paige Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 55. Paige Recent Development
 Table 56. Ibex Company Details
 Table 57. Ibex Business Overview
 Table 58. Ibex AI-powered Cancer Diagnostic Tool Product
 Table 59. Ibex Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 60. Ibex Recent Development
 Table 61. Roche Company Details
 Table 62. Roche Business Overview
 Table 63. Roche AI-powered Cancer Diagnostic Tool Product
 Table 64. Roche Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 65. Roche Recent Development
 Table 66. Volpara Health Limited Company Details
 Table 67. Volpara Health Limited Business Overview
 Table 68. Volpara Health Limited AI-powered Cancer Diagnostic Tool Product
 Table 69. Volpara Health Limited Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 70. Volpara Health Limited Recent Development
 Table 71. Bot Image, Inc. Company Details
 Table 72. Bot Image, Inc. Business Overview
 Table 73. Bot Image, Inc. AI-powered Cancer Diagnostic Tool Product
 Table 74. Bot Image, Inc. Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 75. Bot Image, Inc. Recent Development
 Table 76. Quibim Company Details
 Table 77. Quibim Business Overview
 Table 78. Quibim AI-powered Cancer Diagnostic Tool Product
 Table 79. Quibim Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 80. Quibim Recent Development
 Table 81. Imagene AI Company Details
 Table 82. Imagene AI Business Overview
 Table 83. Imagene AI AI-powered Cancer Diagnostic Tool Product
 Table 84. Imagene AI Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 85. Imagene AI Recent Development
 Table 86. SkinVision Company Details
 Table 87. SkinVision Business Overview
 Table 88. SkinVision AI-powered Cancer Diagnostic Tool Product
 Table 89. SkinVision Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 90. SkinVision Recent Development
 Table 91. NIRAMAI Health Analytix Company Details
 Table 92. NIRAMAI Health Analytix Business Overview
 Table 93. NIRAMAI Health Analytix AI-powered Cancer Diagnostic Tool Product
 Table 94. NIRAMAI Health Analytix Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 95. NIRAMAI Health Analytix Recent Development
 Table 96. Vara Company Details
 Table 97. Vara Business Overview
 Table 98. Vara AI-powered Cancer Diagnostic Tool Product
 Table 99. Vara Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 100. Vara Recent Development
 Table 101. Gleamer Company Details
 Table 102. Gleamer Business Overview
 Table 103. Gleamer AI-powered Cancer Diagnostic Tool Product
 Table 104. Gleamer Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 105. Gleamer Recent Development
 Table 106. Lunit Inc. Company Details
 Table 107. Lunit Inc. Business Overview
 Table 108. Lunit Inc. AI-powered Cancer Diagnostic Tool Product
 Table 109. Lunit Inc. Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 110. Lunit Inc. Recent Development
 Table 111. Monitor Corporation Company Details
 Table 112. Monitor Corporation Business Overview
 Table 113. Monitor Corporation AI-powered Cancer Diagnostic Tool Product
 Table 114. Monitor Corporation Revenue in AI-powered Cancer Diagnostic Tool Business (2020-2025) & (US$ Million)
 Table 115. Monitor Corporation Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. AI-powered Cancer Diagnostic Tool Picture
 Figure 2. Global AI-powered Cancer Diagnostic Tool Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global AI-powered Cancer Diagnostic Tool Market Share by Type: 2024 VS 2031
 Figure 4. Hardware Features
 Figure 5. Software Features
 Figure 6. Global AI-powered Cancer Diagnostic Tool Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global AI-powered Cancer Diagnostic Tool Market Share by Application: 2024 VS 2031
 Figure 8. Skin Cancer Case Studies
 Figure 9. Breast Cancer Case Studies
 Figure 10. Lung Cancer Case Studies
 Figure 11. Other Case Studies
 Figure 12. AI-powered Cancer Diagnostic Tool Report Years Considered
 Figure 13. Global AI-powered Cancer Diagnostic Tool Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global AI-powered Cancer Diagnostic Tool Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global AI-powered Cancer Diagnostic Tool Market Share by Region: 2024 VS 2031
 Figure 16. Global AI-powered Cancer Diagnostic Tool Market Share by Players in 2024
 Figure 17. Global AI-powered Cancer Diagnostic Tool Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by AI-powered Cancer Diagnostic Tool Revenue in 2024
 Figure 19. North America AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America AI-powered Cancer Diagnostic Tool Market Share by Country (2020-2031)
 Figure 21. United States AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe AI-powered Cancer Diagnostic Tool Market Share by Country (2020-2031)
 Figure 25. Germany AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific AI-powered Cancer Diagnostic Tool Market Share by Region (2020-2031)
 Figure 33. China AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America AI-powered Cancer Diagnostic Tool Market Share by Country (2020-2031)
 Figure 41. Mexico AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa AI-powered Cancer Diagnostic Tool Market Share by Country (2020-2031)
 Figure 45. Turkey AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE AI-powered Cancer Diagnostic Tool Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. DermaSensor, Inc. Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 49. Paige Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 50. Ibex Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 51. Roche Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 52. Volpara Health Limited Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 53. Bot Image, Inc. Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 54. Quibim Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 55. Imagene AI Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 56. SkinVision Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 57. NIRAMAI Health Analytix Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 58. Vara Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 59. Gleamer Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 60. Lunit Inc. Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 61. Monitor Corporation Revenue Growth Rate in AI-powered Cancer Diagnostic Tool Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart